Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial

BACKGROUND: Intravenous tranexamic acid (IV TXA) is one of the most effective agents in use for reducing blood loss following total knee arthroplasty (TKA) but its safety regarding venous thromboembolic events (VTEs) remains in question. The direct, local application of TXA may reduce systemic toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinsornsak, P, Rojanavijitkul, S, Chumchuen, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960744/
https://www.ncbi.nlm.nih.gov/pubmed/27455842
http://dx.doi.org/10.1186/s12891-016-1176-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960744/
https://www.ncbi.nlm.nih.gov/pubmed/27455842
http://dx.doi.org/10.1186/s12891-016-1176-7

Ejemplares similares